Lv3
374 积分 2023-02-25 加入
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies
4小时前
已完结
Treatment Decisions in Multiple Myeloma
9天前
已完结
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
15天前
已完结
Optimal CAR-T cell therapy options for patients with multiple myeloma
1个月前
已完结
Diagnosis and Management of Multiple Myeloma
1个月前
已完结
Macrophage migration inhibitory factor superfamily in tumor metabolism: mechanistic insights and therapeutic potential
1个月前
已完结
Single Cell RNA-Seq Analysis Revealed MIF/CD74 Pathway Determinants of BCMA CART Resistance in Relapsed/Refractory Multiple Myeloma
1个月前
已完结
Harnessing neoantigen-specific T cells for precision immunotherapy in hematologic malignancies
1个月前
已完结
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)
1个月前
已完结
Targeting CD74 may mitigate immune-escape features and enhance BCMA CAR-T activity in preclinical models of relapsed/refractory multiple myeloma
2个月前
已完结
皖公网安备34019202002308
